This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Ergothioneine Ameliorates Liver Fibrosis by Inhibiting Glycerophospholipids Metabolism and TGF-β/Smads Signaling Pathway: Based on Metabonomics and Network Pharmacology.
Journal of applied toxicology : JAT, 45(3), 514-530
Citation
Mao, Yaping; Xie, Zhenghui; Zhang, Xiangxia; Fu, Yu; Yu, Xiaotong; Deng, Lili; Zhang, Xiu; Hou, Bo; Wang, Xiao; Ma, Mingyue; Ren, Fu. (2025). Ergothioneine Ameliorates Liver Fibrosis by Inhibiting Glycerophospholipids Metabolism and TGF-β/Smads Signaling Pathway: Based on Metabonomics and Network Pharmacology.. Journal of applied toxicology : JAT, 45(3), 514-530. https://doi.org/10.1002/jat.4728